<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        Completely or well-controlled allergic rhinitis symptoms within the past 4 wk<lb/> 42 (52)<lb/> 52 (59)<lb/> 25 (21)<lb/> 34 (48)<lb/> 44 (52)<lb/> 43 (50)<lb/> 63 (42)<lb/> 49 (81)<lb/> 48 (67)<lb/> Poorly or uncontrolled allergic rhinitis symptoms within the past week<lb/> 13 (10)<lb/> 11 (10)<lb/> 15 (13)<lb/> 25 (14)<lb/> 3 (11)<lb/> 13 (15)<lb/> 7 (0)<lb/> 14 (0)<lb/> 7 (6)<lb/> Seen physician within the past year for allergic rhinitis<lb/> 66 (70)<lb/> 50 (68)<lb/> 75 (63)<lb/> 42 (41)<lb/> 73 (85)<lb/> 73 (90)<lb/> 61 (83)<lb/> 82 (76)<lb/> 80 (72)<lb/> Visited an ear
        <bibl>, nose, and throat; otolaryngologist; or other specialist for allergic rhinitis within the past year<lb/> 49 (30)<lb/> </bibl>

        12 (12)<lb/> 62 (54)<lb/> 24 (10)<lb/> 8 (19)<lb/> 46 (50)<lb/> 9 (17)<lb/> 68 (38)<lb/> 73 (56)<lb/> Visited a pharmacist for advice on the treatment of allergic rhinitis<lb/> 40 (29)<lb/> 62 (63)<lb/> 47 (46)<lb/> 15 (7)<lb/> 30 (30)<lb/> 18 (0)<lb/> 11 (8)<lb/> 24 (10)<lb/> 36 (17)<lb/> Attitudes about treatment for allergic rhinitis (somewhat to strongly agree)<lb/> No truly effective treatments for allergic rhinitis<lb/> 59 (55)<lb/> 49 (42)<lb/> 76 (83)<lb/> 61 (69)<lb/> 40 (37)<lb/> 28 (20)<lb/> 56 (58)<lb/> 66 (72)<lb/> 64 (50)<lb/> The frequency of allergic rhinitis symptoms can be prevented in most cases<lb/> 62 (68)<lb/> 53 (76)<lb/> 69 (50)<lb/> 49 (66)<lb/> 60 (63)<lb/> 77 (85)<lb/> 63 (58)<lb/> 51 (67)<lb/> 72 (67)<lb/> Current allergic rhinitis medication use for allergic rhinitis symptoms<lb/> No medication<lb/> 31 (37)<lb/> 32 (39)<lb/> 28 (33)<lb/> 44 (52)<lb/> 56 (52)<lb/> 7 (10)<lb/> 49 (33)<lb/> 35 (29)<lb/> 9 (22)<lb/> Any medication<lb/> 69 (63)<lb/> 68 (61)<lb/> 72 (67)<lb/> 56 (48)<lb/> 44 (48)<lb/> 93 (90)<lb/> 51 (67)<lb/> 65 (71)<lb/> 89 (78)<lb/> Any prescription medication<lb/> 52 (48)<lb/> 39 (29)<lb/> 58 (63)<lb/> 34 (35)<lb/> 38 (44)<lb/> 73 (65)<lb/> 44 (67)<lb/> 51 (48)<lb/> 81 (67)<lb/> Over-the-counter medication<lb/> 36 (27)<lb/> 46 (44)<lb/> 37 (13)<lb/> 27 (17)<lb/> 11 (4)<lb/> 52 (55)<lb/> 14 (8)<lb/> 22 (19)<lb/> 21 (6)<lb/> Type of allergic rhinitis medication used for allergic rhinitis symptoms<lb/> Corticosteroid nasal spray<lb/> 25 (18)<lb/> 32 (12)<lb/> 33 (29)<lb/> 11 (14)<lb/> 6 (19)<lb/> 21 (20)<lb/> 13 (25)<lb/> 18 (5)<lb/> 28 (33)<lb/> Other Rx<lb/> 37 (37)<lb/> 15 (17)<lb/> 44 (46)<lb/> 25 (28)<lb/> 36 (30)<lb/> 63 (60)<lb/> 36 (42)<lb/> 43 (43)<lb/> 64 (56)<lb/> Subcutaneous immunotherapy<lb/> 22 (23)<lb/> 6 (15)<lb/> 37 (33)<lb/> 0 (0)<lb/> 15 (19)<lb/> 11 (40)<lb/> 66 (83)<lb/> 12 (5)<lb/> 7 (11)<lb/> Sublingual immunotherapy<lb/> 38 (37)<lb/> 20 (15)<lb/> 67 (58)<lb/> 17 (31)<lb/> 23 (27)<lb/> 24 (50)<lb/> 12 (42)<lb/> 48 (43)<lb/> 53 (
        <bibl><label>56)</label><lb/> Homeopathic treatments (e.g., herbal supplements)<lb/> 16 (14)<lb/> </bibl>

        10 (0)<lb/> 19 (4)<lb/> 3 (7)<lb/> 22 (41)<lb/> 16 (25)<lb/> 8 (8)<lb/> 30 (14)<lb/> 29 (
        <bibl><label>0)</label><lb/> S8<lb/> September-October 2011, Vol. 25, No. 5 (Suppl 1)<lb/> </bibl>
<bibl>Proportion of patients who reported being very satisfied with intranasal corticosteroid treatments<lb/> 28 (32)<lb/> </bibl>

        37 (50)<lb/> 9 (0)<lb/> 0 (0)<lb/> 0 (17)<lb/> 67 (50)<lb/> 14 (40)<lb/> 20 (0)<lb/> 48 (11)<lb/> Proportion of patients who reported being very satisfied with over-the-counter treatments<lb/> 27 (40ϫ)<lb/> 39 (46)<lb/> 18 (0)<lb/> 7 (25)<lb/> 0 (0)<lb/> 24 (36)<lb/> 25 (100)<lb/> 0 (0)<lb/> 50 (100)<lb/> INTRANASAL corticosteroid relieves at least most of allergic rhinitis symptoms<lb/> 65 (68)<lb/> 64 (69)<lb/> 58 (50)<lb/> 50 (50)<lb/> 50 (67)<lb/> 91 (88)<lb/> 81 (100)<lb/> 40 (100)<lb/> 70 (56)<lb/> Expected overall percentage of allergic rhinitis symptom relief with intranasal corticosteroid therapy<lb/> 83 (86)<lb/> 85 (83)<lb/> 81 (92)<lb/> 87 (89)<lb/> 77 (93)<lb/> 87 (90)<lb/> 87 (91)<lb/> 77 (67)<lb/> 84 (80)<lb/> Proportion of patients who expect intranasal corticosteroid products to provide symptom relief within 3 hr<lb/> 72 (78)<lb/> 65 (70)<lb/> 84 (100)<lb/> 54 (65)<lb/> 48 (78)<lb/> 77 (71)<lb/> 67 (100)<lb/> 64 (60)<lb/> 74 (100)<lb/> Intranasal corticosteroid products loses effectiveness over the 24-hr treatment interval<lb/> 53 (47)<lb/> 61 (38)<lb/> 63 (50)<lb/> 25 (17)<lb/> 50 (83)<lb/> 33 (25)<lb/> 43 (60)<lb/> 40 (0)<lb/> 11 (78)<lb/> Proportion of patients who reported intranasal corticosteroid effectiveness decreases with chronic use<lb/> 30 (19)<lb/> 41 (21)<lb/> 32 (29)<lb/> 0 (24)<lb/> 10 (0)<lb/> 41 (43)<lb/> 9 (0)<lb/> 8 (20)<lb/> 30 (13)<lb/> Proportion of patients who reported stopping intranasal corticosteroid therapy<lb/> 60 (48)<lb/> 65 (50)<lb/> 62 (50)<lb/> 100 (50)<lb/> 0 (0)<lb/> 38 (33)<lb/> 50 (0)<lb/> 60 (100)<lb/> 67 (0)<lb/> Side effects are less bothersome with other medications used to treat allergic rhinitis compared with intranasal corticosteroid<lb/> 36 (27)<lb/> 26 (19)<lb/> 38 (40)<lb/> 35 (25)<lb/> 57 (17)<lb/> 63 (50)<lb/> 44 (33)<lb/> 41 (0)<lb/> 50 (50)<lb/> Proportion of patients who are not sure if intranasal corticosteroid are safe for long-term use<lb/> 25 (28)<lb/> 19 (15)<lb/> 25 (50)<lb/> 34 (35)<lb/> 30 (26)<lb/> 29 (47)<lb/> 40 (50)<lb/> 22 (10)<lb/> 27 (17)<lb/> 
        <bibl><label>3</label>. How many persons in this household have been diagnosed with<lb/> NAs (hay fever), sinus disease, or AR?<lb/> 4. (Has this person/Have any of these persons) had symptoms<lb/> such as sneezing, itching, watery eyes, nasal congestion, or other NA<lb/> symptoms in the past 12 months?<lb/> 5. (Does this person/Do any of these persons) take any medication<lb/> for their NAs (hay fever), sinus disease, or AR?<lb/> 6. (What is the age/What are the ages) of the person(s) with NAs<lb/> (hay fever), sinus disease, or AR?<lb/> 7. What (is/are) the gender of (that person/those persons)?<lb/> </bibl>
        <bibl><label>8</label>. Has a doctor ever diagnosed (you/your child) as having NAs,<lb/> hay fever, sinus disease, or AR?<lb/> 9. Do you have nasal congestion; repeated sneezing; cough; runny<lb/> nose; or red, watery, or itching eyes at least a few days a week?<lb/> 10. (Do you/ Does your child) still suffer from NAs (hay fever),<lb/> sinus disease, or AR?<lb/> 11. When was the most recent time that (you/your child) experi-<lb/>enced symptoms of NAs for a month or longer?<lb/> 12. In the past 12 months, (have you/has your child) taken med-<lb/>ication to treat (your/his/her) NAs (hay fever), sinus disease, or AR?<lb/> 13. Is there any other person in the household who suffers from<lb/> NAs (hay fever), sinus disease, or AR?<lb/> 14. In general, would you say (your/your child&apos;s) health is excel-<lb/>lent, very good, good, fair, poor, or very poor?<lb/> 15. (Have you /Has your child) ever been diagnosed with asthma?<lb/> 16. (Have you/Has your child) had asthma symptoms or exacer-<lb/>bations in the past 12 months?<lb/> 17. At what age (were you/was your child) first diagnosed with<lb/> NAs (hay fever), sinus disease, or AR?<lb/> 18. What was the medical specialty of the doctor who FIRST<lb/> diagnosed (you/him/her) with NAs?<lb/> 19. (Were you/Was he/she) given a skin test to see what (you<lb/> were/he/she was) allergic to?<lb/> 20. (Were you/Was your child) given a blood test to see what (you<lb/> were/he/she was) allergic to?<lb/> 21. Would you describe (your/his/her) NAs as seasonal or inter-<lb/>mittent or do they occur throughout the year (persistent)?<lb/> 22. In the past 12 months, have (your/his/her) NA symptoms<lb/> been more frequent or worse during a particular season or time of<lb/> year?<lb/> 23. During what particular months of the year are (your/his/her)<lb/> NAs the worst?<lb/> 24. Are (your/his/her) NA symptoms worse when (you are/<lb/> he/she is) outdoors or inside, or is it about the same?<lb/> 25. During the worst 1-month period in the past year, did (you/<lb/> he/she) have-every day, most days a week, a few days a week, a few<lb/> days a month, or less than that?<lb/> 26. When (you have/he/she has) NA attacks, how bothersome are<lb/> the following symptoms usually. Was the (symptom) extremely both-<lb/>ersome, moderately bothersome, slightly bothersome, or not bother-<lb/>some?<lb/> 27. Which of these symptoms was the MOST bothersome to (you/<lb/> </bibl>
him/her)?<lb/> 
        <bibl><label>28</label>. In general, when (you have/ he/she has) a NA attack would<lb/> you say that (your/his/her) discomfort is usually?<lb/> 29. What things usually trigger or make (your/his/her) NA symp-<lb/>toms worse?<lb/> 30. (Have you/Has your child) missed (work/school) in the past<lb/> 12 months because of (your/his/her) NAs?<lb/> 31. How many (work/school) days in the past year (have you/has<lb/> he/she) missed?<lb/> 32. Aside from actually missing (work/school) (have your/ has his/<lb/> her) NA symptoms in the past 12 months interfered with (your/his/her)<lb/> performance at (work/school)?<lb/> 33. Thinking about (your/your child&apos;s) ability to do the things<lb/> (you/he/she) want(s) to on a scale from 0 to 100, where 100 means<lb/> REFERENCES<lb/> 1. Ryan MW. Asthma and rhinitis: Comorbidities. Otolaryngol Clin<lb/> North Am 41:283-295, 2008.<lb/> </bibl>
        <bibl><label>2</label>. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc<lb/> 28:3-9, 2007.<lb/> </bibl>
        <bibl><label>3</label>. Mullol J, Maurer M, and Bousquet J. Sleep and allergic rhinitis.<lb/> J Investig Allergol Clin Immunol 18:415-419, 2008.<lb/> </bibl>
        <bibl><label>4</label>. Nathan RA. The pathophysiology, clinical impact, and management<lb/> of nasal congestion in allergic rhinitis. Clin Ther 30:573-586, 2008.<lb/> </bibl>
        <bibl><label>5</label>. Craig TJ, Ferguson BJ, and Krouse JH. Sleep impairment in allergic<lb/> rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol 29:<lb/> 209-217, 2008.<lb/> </bibl>
        <bibl><label>6</label>. Storms W. Allergic rhinitis-induced nasal congestion: Its impact on<lb/> sleep quality. Prim Care Respir J 17:7-18, 2008.<lb/> </bibl>
        <bibl><label>7</label>. Passalacqua G, Canonica GW, and Baiardini I. Rhinitis, rhinosinus-<lb/>itis, and quality of life in children. Pediatr Allergy Immunol Suppl<lb/> 18:40-45, 2007.<lb/> </bibl>
        <bibl><label>8</label>. Valovirta E, Myrseth SE, and Palkonen S. The voice of the patients:<lb/> Allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin<lb/> Immunol 8:1-9, 2008.<lb/> </bibl>
        <bibl><label>9</label>. Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc<lb/> 31:370-374, 2010.<lb/> </bibl>
        <bibl><label>10</label>. Allergies-American Academy of Allergy Asthma and Immunology.<lb/> Available online at www.AAAAI.org; last accessed August 6, 2010.<lb/> </bibl>
        <bibl><label>11</label>. Sanico AM. Latest development in the management of allergic rhi-<lb/>nitis. Clin Rev Allergy Immunol 27:181-189, 2004.<lb/> </bibl>
        <bibl><label>12</label>. Park HS, Choi GS, Cho JS, and Kim YY. Epidemiology and current<lb/> status of allergic rhinitis, asthma and associated allergic diseases in<lb/> Korea: ARIA Asia-Pacific workshop report. Asian Pac J Allergy<lb/> Immunol 27:167-171, 2009.<lb/> </bibl>
        <bibl><label>13</label>. Bunnag C, Jareoncharsri P, Tantilipikorn P, et al. Epidemiology and<lb/> current status of allergic rhinitis and asthma in Thailand-ARIA<lb/> Asia-Pacific Workshop report. Asian Pac J Allergy Immunol 27:79-<lb/>86, 2009.<lb/> </bibl>
        <bibl><label>14</label>. Pawankar R, Bunnag C, Chen Y, et al. Allergic rhinitis and its impact<lb/> on asthma update (ARIA 2008)-Western and Asian-Pacific perspec-<lb/>tive. Asian Pac J Allergy Immunol 27:237-243, 2009.<lb/> </bibl>
        <bibl><label>15</label>. Robertson CF, Dalton MF, Peat JK, et al. Asthma and other atopic<lb/> diseases in Australian children. Australian arm of the International<lb/> Study of Asthma and Allergy in Childhood. Med J Aust 168:434-438,<lb/> 1998.<lb/> </bibl>
        <bibl><label>16</label>. Kim SY, Yoon SJ, Jo MW, et al. Economic burden of allergic rhinitis<lb/> in Korea. Am J Rhinol Allergy 24:e110-e113, 2010.<lb/> </bibl>
        <bibl><label>17</label>. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma<lb/> Proc 31:375-380, 2010.<lb/> </bibl>
        <bibl><label>18</label>. Romagnani S. The increased prevalence of allergy and the hygiene<lb/> hypothesis: Missing immune deviation, reduced immune suppres-<lb/>sion, or both? Immunology 112:352-363, 2004.<lb/> </bibl>
        <bibl><label>19</label>. Brozek JL, Bousquet J, Baena-Cagnani CE, et al.; Global Allergy and<lb/> Asthma European Network and Grading of Recommendations As-<lb/>sessment, Development and Evaluation Working Group. Allergic<lb/> Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision.<lb/> J Allergy Clin Immunol 126:466-476, 2010.<lb/> </bibl>
        <bibl><label>20</label>. Wallace DV, Dykewicz MS, Bernstein DI, et al.; Joint Task Force on<lb/> Practice; American Academy of Allergy; Asthma &amp; Immunology;<lb/> </bibl>
<bibl>American College of Allergy; Asthma and Immunology; and Joint<lb/> Council of Allergy, Asthma and Immunology. The diagnosis and<lb/> management of rhinitis: An updated practice parameter. J Allergy<lb/> Clin Immunol 122:S1-S-84, 2008.<lb/> </bibl>
        <bibl><label>21</label>. Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident<lb/> asthma cases in adults with allergic rhinitis and effect of allergen<lb/> immunotherapy: A retrospective cohort study. Respir Res 6:153-159,<lb/> 2005.<lb/> </bibl>
        <bibl><label>22</label>. Mullol J. A survey of the burden of allergic rhinitis in Spain. J Investig<lb/> Allergol Clin Immunol 19:27-34, 2009.<lb/> </bibl>
        <bibl><label>23</label>. Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of<lb/> allergic rhinitis in Europe. Allergy 62:17-25, 2007.<lb/> </bibl>
        <bibl><label>24</label>. Blaiss MS, Meltzer EO, Derebery MJ, and Boyle JM. Patient and<lb/> healthcare-provider perspectives on the burden of allergic rhinitis.<lb/> Allergy Asthma Proc 28:S4-S10, 2007.<lb/> </bibl>
        <bibl><label>25</label>. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis:<lb/> Results from the Pediatric Allergies in America survey. J Allergy Clin<lb/> Immunol 124:S43-S70, 2009.<lb/> </bibl>
        <bibl><label>26</label>. Neffen H, Mello JF Jr, Sole D, et al. Nasal allergies in the Latin<lb/> American population: Results from the Allergies in Latin America<lb/> survey. Allergy Asthma Proc 31:S9-S27, 2010.<lb/> </bibl>
        <bibl><label>27</label>. Savage J, and Roy D. Allergic rhinitis: An update. J R Soc Promot<lb/> Health 125:172-175, 2005.<lb/> </bibl>
        <bibl><label>28</label>. Bjorksten B, Clayton T, Ellwood P, et al., for the Phase III Study<lb/> Group II. Worldwide time trends for symptoms of rhinitis and con-<lb/>junctivitis: Phase III of the International Study of Asthma and Aller-<lb/>gies in Childhood. Pediatr Allergy Immunol 19:110-124, 2008.<lb/> </bibl>
        <bibl><label>29</label>. Kim YM, Lee CH, Kim JH, et al. Prevalence of allergic rhinitis on the<lb/> basis of ARIA classification. Korean J Otolaryngol Head Neck Surg<lb/> 49:623-628, 2006.<lb/> </bibl>
        <bibl><label>30</label>. National Asthma Council-Australia. Available online at www.<lb/> nationalasthma.org.au/content/view/158/59/; last accessed August<lb/> 21, 2010.<lb/> </bibl>
        <bibl><label>31</label>. Keith PK, Desrosiers M, Waserman S, and Schellenberg RR. Burden<lb/> of illness of allergic rhinitis in Canada. J Allergy Clin Immunol<lb/> 119:S356, 2007.<lb/> </bibl>
        <bibl><label>32</label>. Benninger MS, and Benninger RM. The impact of allergic rhinitis on<lb/> sexual activity, sleep, and fatigue. Allergy Asthma Proc 30:358-365,<lb/> 2009.<lb/> </bibl>
        <bibl><label>33</label>. Craig TJ, Sherkat A, and Safaee S. Congestion and sleep impairment<lb/> in allergic rhinitis. Curr Allergy Asthma Rep 10:113-121, 2010.<lb/> </bibl>
        <bibl><label>34</label>. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and<lb/> productivity impact of nasal symptoms in the United States: Findings<lb/> from the Burden of Rhinitis in America survey. Allergy Asthma Proc<lb/> 30:244-254, 2009.<lb/> </bibl>
        <bibl><label>35</label>. Stull DE, Schaefer M, Crespi S, and Sandor DW. Relative strength of<lb/> relationships of nasal congestion and ocular symptoms with sleep,<lb/> mood and productivity. Curr Med Res Opin 25:1785-1792, 2009.<lb/> </bibl>
        <bibl><label>36</label>. Hellgren J, Cervin A, Nordling S, et al. Allergic rhinitis and the<lb/> common cold-High cost to society. Allergy 65:776-783, 2010.<lb/> </bibl>
        <bibl><label>37</label>. Borres MP. Allergic rhinitis: More than just a stuffy nose. Acta<lb/> Paediatr 98:1088-1092, 2009.<lb/> </bibl>
        <bibl><label>38</label>. Blaiss MS, and Allergic Rhinitis in Schoolchildren Consensus Group.<lb/> Allergic rhinitis and impairment issues in schoolchildren: A consen-<lb/>sus report. Curr Med Res Opin 20:1937-1952, 2004.<lb/> </bibl>
        <bibl><label>39</label>. Valovirta E, and Pawankar R. Survey on the impact of comorbid<lb/> allergic rhinitis in patients with asthma. BMC Pulm Med 6:S3, 2006.<lb/> </bibl>
        <bibl><label>40</label>. Bunnag C, Leurmarnkul W, Jareoncharsri P, et al. Quality of life<lb/> assessment in Thai patients with allergic rhinoconjunctivitis using the<lb/> SF-36 questionnaire (Thai version). Rhinology 43:99-103, 2005.<lb/> </bibl>
        <bibl><label>41</label>. Ciprandi G, Klersy C, Cirillo I, and Marseglia GL. Quality of life in<lb/> allergic rhinitis: Relationship with clinical, immunological, and func-<lb/>tional aspects. Clin Exp Allergy 37:1528-1535, 2007.<lb/> </bibl>
        <bibl><label>42</label>. Szeinbach SL, Seoane-Vazquez EC, Beyer A, and Williams PB. The<lb/> impact of allergic rhinitis on work productivity. Prim Care Respir J<lb/> 16:98-105, 2007.<lb/> </bibl>
        <bibl><label>43</label>. Tripathi A, and Patterson R. Impact of allergic rhinitis treatment on<lb/> quality of life. Pharmacoeconomics 19:891-899, 2001.<lb/> </bibl>
        <bibl><label>44</label>. Pratt EL, and Craig TJ. Assessing outcomes from the sleep distur-<lb/>bance associated with rhinitis. Curr Opin Allergy Clin Immunol<lb/> 7:249-256, 2007.<lb/> </bibl>
        <bibl><label>45</label>. Kakumanu S, Glass C, and Craig T. Poor sleep and daytime somno-<lb/>lence in allergic rhinitis: Significance of nasal congestion. Am J Respir<lb/> Med 1:195-200, 2002.<lb/> </bibl>
        <bibl><label>46</label>. Santos CB, Pratt EL, Hanks C, et al. Allergic rhinitis and its effect on<lb/> sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immu-<lb/>nol 97:579-586, 2006.<lb/> </bibl>
        <bibl><label>47</label>. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol<lb/> Head Neck Surg 130:617-629, 2004.<lb/> </bibl>
        <bibl><label>48</label>. Davies MJ, Fisher LH, Chegini S, and Craig TJ. A practical approach<lb/> to allergic rhinitis and sleep disturbance management. Allergy<lb/> Asthma Proc 27:224-230, 2006.<lb/> </bibl>
        <bibl><label>49</label>. Woods L, and Craig TJ. The importance of rhinitis on sleep, daytime<lb/> somnolence, productivity and fatigue. Curr Opin Pulm Med 12:390-<lb/>396, 2006.<lb/> </bibl>
        <bibl><label>50</label>. Fang BJ, Tonelli LH, J Soriano J, and Postolache TT. Disturbed sleep:<lb/> Linking allergic rhinitis, mood and suicidal behavior. Front Biosci<lb/> (Schol Ed) 2:30-46, 2010.<lb/> </bibl>
        <bibl><label>51</label>. Yuksel H, Sogut A, Yilmaz H, et al. Sleep actigraphy evidence of<lb/> improved sleep after treatment of allergic rhinitis. Ann Allergy<lb/> Asthma Immunol 103:290-294, 2009.<lb/> </bibl>
        <bibl><label>52</label>. Civelek E, Yavuz S, Boz A, et al. Epidemiology and burden of rhinitis<lb/> and rhinoconjunctivitis in 9-to 11-year old children. Am J Rhinol<lb/> Allergy 24:364-370, 2010. (Epub ahead of print June 24, 2010).<lb/> </bibl>
        <bibl><label>53</label>. Kauppi P, Salo P, Hakola R, et al. Allergic rhinitis alone or with<lb/> asthma is associated with an increased risk of sickness absences.<lb/> Respir Med 104:1654-1658, 2010. (Epub ahead of print June 9, 2010.)<lb/> </bibl>
        <bibl><label>54</label>. Sundberg R, Tore ´n K, Ho ¨glund D, et al. Nasal symptoms are associ-<lb/>ated with school performance in adolescents. J Adolesc Health 40:<lb/> 581-583, 2007.<lb/> </bibl>
        <bibl><label>55</label>. Dodick D. Patient perceptions and treatment preferences in migraine<lb/> management. CNS Drugs 16(suppl 1):19-24, 2002.<lb/> </bibl>
        <bibl><label>56</label>. Wong IY, Soh SE, Chng SY, et al. Compliance with topical nasal<lb/> medication-An evaluation in children with rhinitis. Pediatr Al-<lb/>lergy Immunol 21:1146-1150, 2010. (Epub ahead of print August<lb/> 16, 2010.)<lb/> </bibl>
        <bibl><label>57</label>. Dowson A, Bundy M, Salt R, and Kilminster S. Patient preference for<lb/> triptan formulations: A prospective study with zolmitriptan. Head-<lb/>ache 47:1144-1151, 2007.<lb/> </bibl>
        <bibl><label>58</label>. Khanna P, and Shah A. Assessment of sensory perceptions and<lb/> patient preference for intranasal corticosteroid sprays in allergic rhi-<lb/>nitis. Am J Rhinol 19:316-321, 2005.<lb/> </bibl>
        <bibl><label>59</label>. Meltzer EO, Stahlman JE, Leflein J, et al. Preferences of adult patients<lb/> with allergic rhinitis for the sensory attributes of fluticasone furoate<lb/> versus fluticasone propionate nasal sprays: A randomized, multi-<lb/>center, double-blind, single-dose, crossover study. Clin Ther 30:271-<lb/>299, 2008.<lb/> </bibl>
        <bibl><label>60</label>. Meltzer EO, Bardelas J, Goldsobel A, and Kaiser H. A preference<lb/> evaluation study comparing the sensory attributes of mometasone<lb/> furoate and fluticasone propionate nasal sprays by patients with<lb/> allergic rhinitis. Treat Respir Med 4:289-296, 2005.<lb/> </bibl>
        <bibl><label>61</label>. Shah SR, Miller C, Pethick N, et al. Two multicenter, randomized,<lb/> single-blind, single-dose, crossover studies of specific sensory attri-<lb/>butes of budesonide aqueous nasal spray and fluticasone propionate<lb/> nasal spray. Clin Ther 25:2198-2204, 2003.<lb/> </bibl>
        <bibl><label>62</label>. Mahadevia PJ, Shah S, Leibman C, et al. Patient preferences for<lb/> sensory attributes of intranasal corticosteroids and willingness to<lb/> adhere to prescribed therapy for allergic rhinitis: A conjoint analysis.<lb/> Ann Allergy Asthma Immunol 93:345-350, 2004.<lb/> </bibl>
        <bibl><label>63</label>. Wingertzahn MA, Derebery MJ, and Nelson HS. Optimization of<lb/> intranasal corticosteroid formulations for the treatment of allergic<lb/> rhinitis. Allergy Asthma Proc 28(suppl 1):S18-S24, 2007.<lb/> e</bibl>
        </listBibl>
    </text>
</tei>

